Medical Advisory Board
DSF’s Medical Advisory Board (MAB) is comprised of recognized authorities in the clinical treatment of Dravet syndrome. Their role is to provide strategic advice and counsel to support the mission of DSF. The MAB offers input on clinical trials that impact the Dravet community; serve as a representative link between DSF and the medical community; and update the best practices for the International Dravet Syndrome Treatment Consensus.
Linda Laux, MD
Ann & Robert H. Lurie Children's Hospital
Danielle Andrade, MD, MSc, FRCPC
University of Toronto
Kelly Knupp, MD, MSCS
Children's Hospital Colorado
Sookyong Koh, MD, PhD
University of Nebraska
Ingrid Scheffer, AO MB BS PhD FRACP FAHMS FAA
University of Melbourne
M. Scott Perry, MD
Cook Children's Medical Center
Joseph Sullivan, MD
University of California San Francisco
Elaine Wirrell, MD
Mayo Clinic
Scientific Advisory Board
DSF’s Scientific Advisory Board (SAB) oversees the organization’s research activities. They review and approve all research grant applications and meet annually with other interested researchers and scientists to discuss innovative and promising research in the field of Dravet syndrome and associated epilepsies at DSF’s Research Roundtable.
Jack Parent, MD
Board Co-Chair University of Michigan Medical Center
Lori Isom, PhD
Board Co-Chair University of Michigan Medical Center
Dennis Dlugos, MD, MSCE
Children's Hospital of Philadelphia
Ethan Goldberg, MD, PhD
Children's Hospital of Philadelphia
Jennifer Kearney, PhD
Northwestern University
Heather C. Mefford, MD, PhD
St. Jude's Research Hospital
Miriam Meisler, PhD
University of Michigan Medical Center
Sarah Weckhuysen, MD, PhD
University of Antwerp in Belgium
Gaia Colasante, PhD
IRCCS Ospendale San Raffaele
